- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
CTI files for initial public offering
PET developer CTI may soon go public. The privately held firm based in Knoxville, TN, has filed with the Securities and Exchange Commission to issue an IPO. The company hopes to raise about $230 million, according to Wall Street Research Net. The lead
PET developer CTI may soon go public. The privately held firm based in Knoxville, TN, has filed with the Securities and Exchange Commission to issue an IPO. The company hopes to raise about $230 million, according to Wall Street Research Net. The lead underwriter will be CS First Boston. CTI had annual revenues of $188.9 million and net income of $6.4 million in fiscal 2001, which ended Sept. 30. The company employs 620 full- and part-time staff, according to WSRN.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
